HTAC Recommends COVID-19 Vaccine Booster and Additional dose: Guidance and Conditions on Implementation

Posted on

HTAC Recommends COVID-19 Vaccine Booster and Additional dose: Guidance and Conditions on Implementation Released on 15 November 2021 Link to ES: Booster and Additional Dose Vaccination for the prevention of COVID-19 While the HTAC recognizes the primary importance of reaching high vaccination coverage for protection against hospitalization, severe disease and death due to COVID-19, HTAC released its preliminary recommendations continue reading : HTAC Recommends COVID-19 Vaccine Booster and Additional dose: Guidance and Conditions on Implementation

HTAC Guidance: COVID-19 Vaccination among the Adolescent Population

Posted on

HTAC notes in a recent recommendation that the DOH can further implement COVID-19 Vaccines Pfizer-BioNTech and Moderna in adolescents aged 12-17 years old for 2022. Link to HTAC Recommendation:  [Vax 2022] Pedia ES_For HTAC Link to Filipino Version:  Gabay ng HTAC para sa Pagbabakuna ng Kabataang Pilipino COVID-19 Vaccines under Emergency Use Authorization (EUA) The Food and Drug Administration (FDA) issues Emergency continue reading : HTAC Guidance: COVID-19 Vaccination among the Adolescent Population

Gabay ng HTAC para sa Pagbabakuna ng Kabataang Pilipino

Posted on

Inirerekomenda ng HTAC na maaring gamitin sa pagbabakuna ng mga kabataang 12-17 taong gulang ang mga COVID-19 vaccine na Pfizer-BioNTech at Moderna sa 2022. Link sa HTAC Recommendation: Pediatric Vaccination for the prevention of COVID-19 Link sa English Version: HTAC Guidance: COVID-19 Vaccination among the Adolescent Population Mga Bakuna para sa COVID-19 na sakop ng Emergency Use Authorization o EUA Ang Food and Drug Administration Philippines (FDA Philippines) ay continue reading : Gabay ng HTAC para sa Pagbabakuna ng Kabataang Pilipino